Clinical Trial Update: Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 [Phase 2]

View source ↗

Summary

Phase II study evaluating an adenovirus PSA vaccine in men with recurrent prostate cancer after local therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Adenovirus/PSA vaccine

Snippet

Sponsor: David M Lubaroff | Conditions: Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-05-18